Filing Details

Accession Number:
0001179110-18-002115
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-14 18:15:12
Reporting Period:
2018-02-12
Accepted Time:
2018-02-14 18:15:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1690763 M Scott Storer C/O Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge MA 02142
Svp, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-02-14 3,972 $15.16 44,783 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2018-02-12 55,000 $0.00 55,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
55,000 No 4 A Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. Includes 755 shares acquired under the issuer's employee stock purchase plan at a purchase price of $14.07 per share on January 31, 2018.
  3. Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
  4. Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.